HWM_research_NEW COPY

The chart shows the growth of an initial investment of $10,000 in HWM_research_NEW COPY, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jul 29, 2021, HWM_research_NEW COPY's average daily return is +0.18%, while the average monthly return is +3.59%. At this rate, an investment would double in approximately 1.6 years.

Historically, 55% of months were positive and 45% were negative. The best month was May 2025 with a return of +27.0%, while the worst month was Apr 2022 at -18.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, HWM_research_NEW COPY closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +15.6%, while the worst single day was Aug 5, 2021 at -10.0%.

HWM_research_NEW COPY has an annualized alpha of 27.93%, beta of 1.59, and R2 of 0.48 versus S&P 500 Index. Calculated based on daily prices since July 29, 2021.

• This portfolio captured 221.22% of S&P 500 Index gains but only 87.34% of its losses - a favorable profile for investors.
• R2 of 0.48 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.

HWM_research_NEW COPY has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

HWM_research_NEW COPY ranks 16 for risk / return — in the bottom 16% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current HWM_research_NEW COPY Sharpe ratio is 1.24 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.56 to 2.44, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of HWM_research_NEW COPY compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

HWM_research_NEW COPY provided a 0.08% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the HWM_research_NEW COPY. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the HWM_research_NEW COPY was 54.08%, occurring on Jun 16, 2022. Recovery took 418 trading sessions.

The current HWM_research_NEW COPY drawdown is 7.31%.

The chart below shows the rolling one-month volatility.